Delivery Order SPE2DB20D6035-SPE2DB25FLYDK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Modafinil 100 mg tablets in unit dose packaging of 30 count at a ceiling value of $1,317.75. The contract employs firm fixed pricing with an ultimate completion date of July 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) under a firm fixed-price contract valued at $4,265.14. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a $3,843.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Modafinil 100 mg tablets in 30-count quantities. This non-set-aside delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, is scheduled for completion by July 22, 2025, with performance conducted at the contractor's Conshohocken, Pennsylvania facility....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30, with a ceiling value of $1,844.46. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) on July 18, 2025, with a ceiling value of $4,118.73 and an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child action under...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,692,616 tablets of Modafinil 100 mg. The $1,226.99 contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations for this award. This contract is likely part of a larger indefinite delivery contract (IDC) valued...
- This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,798.56 firm fixed-price delivery order is for 4,567,880,646 units of Modafinil 200 mg tablets. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg Modafinil tablets. The contract has a ceiling value of $7,153.61 and a period of performance through May 16, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract (SPE2DB20D2104|SPE2DB24FT49C) worth $4,057.38 to provide 4,564,196,494 units of Modafinil 200 mg tablets. This order falls under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,035.96, is for the supply of 4,565,218,326 units of Modafinil 200 mg tablets in 30-count packages. The contract has a firm fixed price and an ultimate completion date of July 23, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB25FLYDKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Modafinil 200 mg tablets in quantities of 30, with a contract ceiling value of $1,055.12. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitive award with no set-aside designation. The contract is performed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters and primary distribution hub for federal pharmaceutical procurement. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply medications, medical devices, and healthcare commodities to military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/18/25 |